Large-scale mesenchymal stem/stromal cell expansion: A visualization tool for bioprocess comparison

Tissue Engineering - Part B: Reviews

Volumn 22, Issue 6, 2016, Pages 485-498

  Lambrechts, Toon ^a   Sonnaert, Maarten ^a   Schrooten, Jan ^a,b   Luyten, Frank P ^a,c   Aerts, Jean Marie ^a   Papantoniou, Ioannis ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Antleron BVBA   (Belgium)

^c SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

Author keywords

bioprocess visualization; bioreactor; cell therapy; comparability; mesenchymal stem cells; scale up

Indexed keywords

BENCHMARKING; BIOREACTORS; CELLS; COST EFFECTIVENESS; CYTOLOGY; EFFICIENCY; EXPANSION; STEM CELLS; VISUALIZATION;

BIOPROCESSES; CELL THERAPY; COMPARABILITY; MESENCHYMAL STEM CELL; SCALE-UP;

CELL CULTURE;

BIOPROCESS; CELL CULTURE; CULTURE VESSEL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; REVIEW; STEM CELL EXPANSION; BIOLOGICAL THERAPY; BIOREACTOR; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; COMPARATIVE STUDY;

BIOREACTORS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 85020547082     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2016.0111     Document Type: Review

References (90)

1. Heathman, T.R.J., Nienow, A.W., McCall, M.J., Coopman, K., Kara, B., and Hewitt, C.J. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med 10, 49, 2015.
2. Trounson, A., and McDonald, C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17, 11, 2015.
3. Mason, C., and Culme-Seymour, E. Cell therapy commercialization-Transformative therapies, economic activity and reducing public healthcare costs. J Tissue Eng Regen Med 8, 17, 2014.
4. Culme-Seymour, E.J., Edwards-Parton, S., Carmen, J., Folkerts, W., Smith, D., and Mason, C. A new cell therapy sector arising from the convergence of cell and gene therapy. Cytotherapy 15, S52, 2013.
5. Jung, S., Panchalingam, K.M., Wuerth, R.D., Rosenberg, L., and Behie, L.A. Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Biochem 59, 106, 2012.
6. Simaria, A.S., Hassan, S., Varadaraju, H., Rowley, J., Warren, K., Vanek, P., et al. Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnol Bioeng 111, 69, 2014.
7. Galipeau, J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 15, 2, 2013.
8. Hourd, P., Ginty, P., Chandra, A., and Williams, D.J. Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability. Cytotherapy 16, 1033, 2014.
9. Kaiser, A.D., Assenmacher, M., Schroder, B., Meyer, M., Orentas, R., Bethke, U., et al. Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Ther 22, 72, 2015.
10. Salmikangas, P., Menezes-Ferreira, M., Reischl, I., Tsiftsoglou, A., Kyselovic, J., Borg, J.J., et al. Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use. Regen Med 10, 65, 2015.
11. Csaszar, E., Chen, K., Caldwell, J., Chan, W., and Zandstra, P.W. Real-Time monitoring and control of soluble signaling factors enables enhanced progenitor cell outputs from human cord blood stem cell cultures. Biotechnol Bioeng 111, 1258, 2013.
12. Leijten, J., Chai, Y.C., Papantoniou, I., Geris, L., Schrooten, J., and Luyten, F.P. Cell based advanced therapeutic medicinal products for bone repair: keep it simple? Adv Drug Deliv Rev 30, 2015.
13. dos Santos, F.F., Andrade, P.Z., da Silva, C.L., and Cabral, J.M.S. Bioreactor design for clinical-grade expansion of stem cells. Biotechnol J 8, 644, 2013.
14. Kumar, A., and Starly, B. Large scale industrialized cell expansion: producing the critical raw material for biofabrication processes. Biofabrication 7, 044103, 2015.
15. Cierpka, K., Elseberg, C.L., Niss, K., Kassem, M., Salzig, D., and Czermak, P. hMSC production in disposable bioreactors with regards to GMP and PAT. Chem Ing Tech 85, 67, 2013.
16. Mendicino, M., Bailey, A.M., Wonnacott, K., Puri, R.K., and Bauer, S.R. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 14, 141, 2014.
17. Bianco, P., Robey, P.G., and Simmons, P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313, 2008.
18. Harris, D.T., and Rogers, I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2, 301, 2007.
19. Ogura, F., Wakao, S., Kuroda, Y., Tsuchiyama, K., Bagheri, M., Heneidi, S., et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev 23, 717, 2014.
20. De Bari, C., Dell Accio, F., Tylzanowski, P., and Luyten, F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44, 1928, 2001.
21. De Bari, C., Dell Accio, F., and Luyten, F.P. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44, 85, 2001.
22. Heathman, T.R.J., Rafiq, Q.A., Chan, A.K.C., Coopman, K., Nienow, A.W., Kara, B., et al. Characterisation of human mesenchymal stem cells from multiple donors and the implications for large scale bioprocess development. Biochem Eng J 108, 14, 2016.
23. Fennema, E.M., Renard, A.J.S., Leusink, A., van Blitterswijk, C.A., and de Boer, J. The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta Orthop 80, 618, 2009.
24. Oedayrajsingh-Varma, M.J., van Ham, S.M., Knippenberg, M., Helder, M.N., Klein-Nulend, J., Schouten, T.E., et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166, 2006.
25. Sotiropoulou, P.A., Perez, S.A., Salagianni, M., Baxevanis, C.N., and Papamichail, M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462, 2006.
26. Dos Santos, F., Campbell, A., Fernandes-Platzgummer, A., Andrade, P.Z., Gimble, J.M., Wen, Y., et al. A xenogeneicfree bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells. Biotechnol Bioeng 111, 1116, 2014.
27. Nold, P., Brendel, C., Neubauer, A., Bein, G., and Hackstein, H. Good manufacturing practice-compliant animalfree expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor. Biochem Biophys Res Commun 430, 325, 2013.
28. Timmins, N.E., Palfreyman, E., Marturana, F., Dietmair, S., Luikenga, S., Lopez, G., et al. Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells. Biotechnol Bioeng 104, 832, 2009.
29. Lambrechts, T., Papantoniou, I., Viazzi, S., Bovy, T., Schrooten, J., Luyten, F.P., et al. Evaluation of a monitored multiplate bioreactor for large-scale expansion of human periosteum derived stem cells for bone tissue engineering applications. Biochem Eng J 108, 58, 2015.
30. Tan, K.Y., Teo, K.L., Lim, J.F., Chen, A.K., Reuveny, S., and Oh, S.K. Serum-free media formulations are cell linespecific and require optimization for microcarrier culture. Cytotherapy 17, 1152, 2015.
31. Heathman, T.R.J., Glyn, V.A.M., Picken, A., Rafiq, Q.A., Coopman, K., Nienow, A.W., et al. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng 112, 1696, 2015.
32. Gottipamula, S., Muttigi, M.S., Kolkundkar, U., and Seetharam, R.N. Serum-free media for the production of human mesenchymal stromal cells: a review. Cell Prolif 46, 608, 2013.
33. Sart, S., Agathos, S.N., and Li, Y. Engineering stem cell fate with biochemical and biomechanical properties of microcarriers. Biotechnol Prog 29, 1354, 2013.
34. Ma, T., Tsai, A.C., and Liu, Y. Biomanufacturing of human mesenchymal stem cells in cell therapy: influence of microenvironment on scalable expansion in bioreactors. Biochem Eng J [Epub ahead of print]; DOI: 10.1016/ j.bej.2015.07.014, 2015.
35. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
36. Sharma, R.R., Pollock, K., Hubel, A., and McKenna, D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54, 1418, 2014.
37. Larson, B.L., Ylostalo, J., Lee, R.H., Gregory, C., and Prockop, D.J. Sox11 Is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A 16, 3385, 2010.
38. Nienow, A.W., Hewitt, C.J., Heathman, T.R.J., Glyn, V.A.M., Fonte, G.N., Hanga, M.P., et al. Agitation conditions for the culture and detachment of hMSCs from microcarriers in multiple bioreactor platforms. Biochem Eng J 108, 24, 2016.
39. Tan, K.Y., Reuveny, S., and Oh, S.K. Recent advances in serum-free microcarrier expansion of mesenchymal stromal cells: parameters to be optimized. Biochem Biophys Res Commun 473, 769, 2015.
40. Balint, R., Richardson, S.M., and Cartmell, S.H. Lowdensity subculture: a technical note on the importance of avoiding cell-To-cell contact during mesenchymal stromal cell expansion. J Tissue Eng Regen Med 9, 1200, 2015.
41. Lambrechts, T., Papantoniou, I., Rice, B., Schrooten, J., Luyten, F.P., and Aerts, J.M. Large-scale autologous stem cell expansion in monitored hollow fibre bioreactors: evaluation of donor-To-donor variability. Cytotherapy [Epub ahead of print]; DOI: 10.1016/j.jcyt.2016.05.013, 2016.
42. Jenkins, M.J., and Farid, S.S. Human pluripotent stem cellderived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J 10, 83, 2015.
43. Hassan, S., Simaria, A.S., Varadaraju, H., Gupta, S., Warren, K., and Farid, S.S. Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions. Regen Med 10, 591, 2015.
44. Nienow, A.W., Rafiq, Q.A., Coopman, K., and Hewitt, C.J. A potentially scalable method for the harvesting of hMSCs from microcarriers. Biochem Eng J 85, 79, 2014.
45. Sonnaert, M., Luyten, F.P., Schrooten, J., and Papantoniou, I. Bioreactor-based online recovery of human progenitor cells with uncompromised regenerative potential: a bone tissue engineering perspective. PloS One 10, e0136875, 2015.
46. Diogo, M.M., da Silva, C.L., and Cabral, J.M.S. Separation technologies for stem cell bioprocessing. Biotechnol Bioeng 109, 2699, 2012.
47. Cunha, B., Aguiar, T., Silva, M.M., Silva, R.J.S., Sousa, M.F.Q., Pineda, E., et al. Exploring continuous and integrated strategies for the up-And downstream processing of human mesenchymal stem cells. J Biotechnol 213, 97, 2015.
48. Cunha, B., Peixoto, C., Silva, M.M., Carrondo, M.J.T., Serra, M., and Alves, P.M. Filtration methodologies for the clarification and concentration of human mesenchymal stem cells. J Membr Sci 478, 117, 2015.
49. Tostoes, R., Dodgson, J., Mason, C., and Veraitch, F. A novel filtration device for point of care preparation of cellular therapies. Cytotherapy 17, S26, 2015.
50. Cunha, B., Silva, R.J., Aguiar, T., Serra, M., Daicic, J., Maloisel, J.L., et al. Improving washing strategies of human mesenchymal stem cells using negative mode expanded bed chromatography. J Chromatogr A 1429, 292, 2016.
51. Bravery, C.A., and French, A. Reference materials for cellular therapeutics. Cytotherapy 16, 1187, 2014.
52. Kinzebach, S., and Bieback, K. Expansion of mesenchymal stem/stromal cells under xenogenic-free culture conditions. Adv Biochem Eng Biotechnol 129, 33, 2013.
53. Dolgin, E. Better standards sought for range of stem cells entering the clinic. Nat Med 20, 797, 2014.
54. Deans, R. Towards the creation of a standard MSC line as a calibration tool. Cytotherapy 17, 1167, 2015.
55. Viswanathan, S., Keating, A., Deans, R., Hematti, P., Prockop, D., Stroncek, D.F., et al. Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. Stem Cells Dev 23, 1157, 2014.
56. McKenna, D., Matthay, M.A., and Pati, S. Correspondence to: soliciting strategies for developing cell-based reference materials to advance mesenchymal stem/stromal cell research and clinical translation. Stem Cells Dev 23, 1717, 2014.
57. Culme-Seymour, E.J., Davies, J.L., Hitchcock, J., Mason, J., Carpenter, M.K., and Mason, C. Cell therapy regulatory toolkit: an online regulatory resource. Regen Med 10, 531, 2015.
58. Viazzi, S., Lambrechts, T., Schrooten, J., Papantoniou, I., and Aerts, J.M. Real-Time characterisation of the harvesting process for adherent mesenchymal stem cell cultures based on on-line imaging and model-based monitoring. Biosyst Eng 138, 104, 2015.
59. Lambrechts, T., Papantoniou, I., Sonnaert, M., Schrooten, J., and Aerts, J.M. Model-based cell number quantification using online single-oxygen sensor data for tissue engineering perfusion bioreactors. Biotechnol Bioeng 111, 1982, 2014.
60. Bravery, C.A., Carmen, J., Fong, T., Oprea, W., Hoogendoorn, K.H., Woda, J., et al. Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy 15, 9, 2013.
61. Hanley, P.J., Mei, Z.Y., Durett, A.G., Cabreira-Harrison, M.D., Klis, M., Li, W., et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the quantum cell expansion system. Cytotherapy 16, 1048, 2014.
62. Tsai, A.C., Liu, Y., and Ma, T. Expansion of human mesenchymal stem cells in fibrous bed bioreactor. Biochem Eng J 108, 51, 2015.
63. Eibes, G., dos Santos, F., Andrade, P.Z., Boura, J.S., Abecasis, M.M.A., da Silva C.L., et al. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146, 194, 2010.
64. Sun, L.Y., Hsieh, D.K., Syu, W.S., Li, Y.S., Chiu, H.T., and Chiou, T.W. Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential. Cell Prolif 43, 445, 2010.
65. Hewitt, C.J., Lee, K., Nienow, A.W., Thomas, R.J., Smith, M., and Thomas, C.R. Expansion of human mesenchymal stem cells on microcarriers. Biotechnol Lett 33, 2325, 2011.
66. dos Santos, F., Andrade, P.Z., Abecasis, M.M., Gimble, J.M., Chase, L.G., Campbell, A.M., et al. Toward a clinicalgrade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xenofree conditions. Tissue Eng Part C Methods 17, 1201, 2011.
67. Rafiq, Q.A., Brosnan, K.M., Coopman, K., Nienow, A.W., and Hewitt, C.J. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-Tank bioreactor. Biotechnol Lett 35, 1233, 2013.
68. Sousa, M.F.Q., Silva, M.M., Roldao, A., Alves, P.M., Serra, M., Giroux, D., et al. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, vertical-wheel bioreactor system: impact of bioreactor design on performance of microcarrier-based cell culture processes. Biotechnol Prog 31, 1600, 2015.
69. Goh, T.K., Zhang, Z.Y., Chen, A.K., Reuveny, S., Choolani, M., Chan, J.K., et al. Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells. BioRes Open Access 2, 84, 2013.
70. Caruso, S.R., Orellana, M.D., Mizukami, A., Fernandes, T.R., Fontes, A.M., Suazo, C.A., et al. Growth and functional harvesting of human mesenchymal stromal cells cultured on a microcarrier-based system. Biotechnol Prog 30, 889, 2014.
71. Weber, C., Freimark, D., Portner, R., Pino-Grace, P., Pohl, S., Wallrapp, C., et al. Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier-part A: inoculation, cultivation, and cell harvest procedures. Int J Artif Organs 33, 512, 2010.
72. Sonnaert, M., Papantoniou, I., Luyten, F.P., and Schrooten, J. Perfusion bioreactor expansion and dynamic harvest preserve in vivo bone forming capacity of osteoprogenitor cells. J Tissue Eng Regen Med 8, 48, 2014.
73. Reichardt, A., Polchow, B., Shakibaei, M., Henrich, W., Hetzer, R., and Lueders, C. Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J 7, 50, 2013.
74. Schirmaier, C., Jossen, V., Kaiser, S.C., Jungerkes, F., Brill, S., Safavi-Nab, A., et al. Scale-up of adipose tissuederived mesenchymal stem cell production in stirred singleuse bioreactors under low-serum conditions. Eng Life Sci 14, 292, 2014.
75. Elseberg, C.L., Leber, J., Salzig, D., Wallrapp, C., Kassem, M., Kraume, M., et al. Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics. Int J Artif Organs 35, 93, 2012.
76. Kaiser, S.C. Characterization and of single-use bioreactors and biopharmaceutical production processes using computational fluid dynamics Doctoral Degree Fakultät III-Prozesswissenschaften, Technische Universität Berlin, 2015.
77. Jossen, V., Kaiser, S.C., Schirmaier, C., Herrmann, J., Tappe, A., Eibl, D., et al. Modification and qualification of a stirred single-use bioreactor for the improved expansion of human mesenchymal stem cells at benchtop scale. Pharmaceut Bioprocess 2, 311, 2014.
78. Pardo, A.M.P., Sherman, H.A., Strathearn, K.E., and Rothenberg, M.E. Xeno-free expansion of functional hMSCs using corning-HYPER technology and corning cellgro-stemgro-hMSC medium, 2012. Available at: http://csmedia2.corning.com/LifeSciences/media/pdf/ISCT-Sept2013-Poster.pdf (accessed August 9, 2016).
79. Pardo, A.M.P., and Rothenberg, M.E. Expansion of human mesenchymal stem cells using corning-hyper technology cell culture vessels. Technical report from the Corning development group, 2012. http://csmedia2.corning.com/ LifeSciences/media/pdf/snappshots-208-Expansn-of-hMSC-Using-Corning-HYPER-Technology%20CC-Vessels.pdf
80. Rojewski, M.T., Fekete, N., Baila, S., Nguyen, K., Furst, D., Antwiler, D., et al. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplant 22, 1981, 2013.
81. Lechanteur, C., Baila, S., Janssens, M.E., Giet, O., Briquet, A., Baudoux, E., et al. Large-scale clinical expansion of mesenchymal stem cells in the GMP-compliant, closed automated quantum-cell expansion system: comparison with expansion in traditional T-flasks. J Stem Cell Res Ther 4, 1, 2014.
82. Jones, M., Varella-Garcia, M., Skokan, M., Bryce, S., Schowinsky, J., Peters, R., et al. Genetic stability of bone marrow-derived human mesenchymal stromal cells in the quantum system. Cytotherapy 15, 1323, 2013.
83. Bartmann, C., Rohde, E., Schallmoser, K., Purstner, P., Lanzer, G., Linkesch, W., et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47, 1426, 2007.
84. Capelli, C., Pedrini, O., Valgardsdottir, R., Da Roit, F., Golay, J., and Introna, M. Clinical grade expansion of MSCs. Immunol Lett 168, 222, 2015.
85. Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Stadelmeyer, E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436, 2007.
86. Reinisch, A., Bartmann, C., Rohde, E., Schallmoser, K., Bjelic-Radisic, V., Lanzer, G., et al. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2, 371, 2007.
87. Fekete, N., Rojewski, M.T., Furst, D., Kreja, L., Ignatius, A., Dausend, J., et al. GMP-compliant isolation and largescale expansion of bone marrow-derived MSC. PloS One 7, e43255, 2012.
88. Hervy, M., Weber, J.L., Pecheul, M., Dolley-Sonneville, P., Henry, D., Zhou, Y., et al. Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions. PloS One 9, e92120, 2014.
89. Petry, F.S.J., Leber, J., Salzig, D., Czermak, P., and Weiss, M.L. Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use. Stem Cells Int 2016, 4834616, 2016.
90. Chen, A.K.L., Chew, Y.K., Tan, H.Y., Reuveny, S., and Oh, S.K.W. Increasing efficiency of human mesenchymal stromal cell culture by optimization of microcarrier concentration and design of medium feed. Cytotherapy 17, 163, 2015.